Joseph Ciccolini

My current work focus on anticancer drugs pharmacokinetics and pharmacogenetics. This, include developing adaptive dosing strategies, and pre-therapeutic testing for anticipating drug-related tox at the bedside. Non-clinical activities include testing novel combinational therapies and/or modalities of administration (e.g., metronomic chemotherapies, liposomal drugs), either in vitro and in tumor-bearing animals.